We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.92B
AUM Growth
-$118M
Cap. Flow
-$387M
Cap. Flow %
-5.59%
Top 10 Hldgs %
73.6%
Holding
128
New
2
Increased
25
Reduced
68
Closed
5

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$13.6M
2
C icon
Citigroup
C
+$10.3M
3
ECL icon
Ecolab
ECL
+$9.75M
4
AMZN icon
Amazon
AMZN
+$8.59M
5
HD icon
Home Depot
HD
+$8.35M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$300M
2
META icon
Meta Platforms (Facebook)
META
+$53.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$42.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.74M

Sector Composition

Rank Sector Weight
1 Financials 30.75%
2 Consumer Discretionary 19.53%
3 Communication Services 15.03%
4 Healthcare 13.85%
5 Materials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PF
101
DELISTED
Pinnacle Foods, Inc.
PF
$1.02M 0.01%
+17,200
New +$969K
T icon
102
AT&T
T
$164B
$941K 0.01%
32,041
– –
GOOGL icon
103
Alphabet (Google) Class A
GOOGL
$4.12T
$915K 0.01%
17,380
-243,000
-93% -$12.5M
DCOY
104
Decoy Therapeutics
DCOY
$2.14M
– –
0
– –
FIS icon
105
Fidelity National Information Services
FIS
$24.2B
$756K 0.01%
8,030
– –
VLRX
106
DELISTED
VALERITAS HOLDINGS INC
VLRX
$704K 0.01%
12,349
– –
JPM icon
107
JPMorgan Chase
JPM
$916B
$687K 0.01%
6,427
-3,873
-38% -$392K
PFNX
108
DELISTED
Pfenex Inc.
PFNX
$666K 0.01%
250,300
-21,100
-8% -$58.4K
AZO icon
109
AutoZone
AZO
$51.3B
$595K 0.01%
837
– –
GPRK icon
110
GeoPark
GPRK
$609M
$504K 0.01%
+51,003
New +$453K
BLUE
111
DELISTED
bluebird bio
BLUE
$385K 0.01%
167
-24
-13% -$48.7K
SIOX
112
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$384K 0.01%
9,113
-887
-9% -$39.8K
ESPR
113
DELISTED
Esperion Therapeutics
ESPR
$292K ﹤0.01%
4,433
-579
-12% -$31.2K
IONS icon
114
Ionis Pharmaceuticals
IONS
$8.93B
$233K ﹤0.01%
4,634
-651
-12% -$35.7K
ACAD icon
115
Acadia Pharmaceuticals
ACAD
$4.51B
$218K ﹤0.01%
7,254
-1,007
-12% -$32.2K
RDUS
116
DELISTED
Radius Health, Inc.
RDUS
$206K ﹤0.01%
6,488
-865
-12% -$27.1K
TSRO
117
DELISTED
TESARO, Inc.
TSRO
$205K ﹤0.01%
2,473
-18,443
-88% -$1.81M
XLRN
118
DELISTED
Acceleron Pharma
XLRN
$198K ﹤0.01%
4,662
-714
-13% -$26.8K
AGIO icon
119
Agios Pharmaceuticals
AGIO
$2.08B
$183K ﹤0.01%
3,200
-600
-16% -$37.8K
KPTI icon
120
Karyopharm Therapeutics
KPTI
$155M
$154K ﹤0.01%
1,070
-164
-13% -$26.3K
LXRX icon
121
Lexicon Pharmaceuticals
LXRX
$1.03B
$140K ﹤0.01%
14,201
-1,945
-12% -$20.2K
SNDX icon
122
Syndax Pharmaceuticals
SNDX
$1.7B
$101K ﹤0.01%
11,500
-1,800
-14% -$17.8K
ICPT
123
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$75K ﹤0.01%
1,284
-133
-9% -$8.39K
ARMK icon
124
Aramark
ARMK
$15B
– –
-21,329
Closed -$625K
BAP icon
125
Credicorp
BAP
$30.5B
– –
-2,216
Closed -$455K
2 3 4
5
6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2017 Portfolio in Review

As of Q4 2017, C WorldWide Group held 128 positions worth $6.92B, down 1.7% from $7.04B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group withdrew a net $387M in Q4 2017, closing 5 positions and reducing 68 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, C WorldWide Group opened a new position in Pinnacle Foods, Inc. worth $1.02M.

  • C WorldWide Group's largest Q4 2017 buy was Pinnacle Foods, Inc.: 17,200 shares worth $1.02M.
  • C WorldWide Group added most to Visa in Q4 2017, an estimated $13.6M increase.
  • C WorldWide Group's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $300M.
  • C WorldWide Group fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $5.74M.
  • C WorldWide Group's ten largest holdings make up 74% of its $6.92B portfolio in Q4 2017.
  • C WorldWide Group opened 2 new positions and closed 5 in Q4 2017.
  • C WorldWide Group's portfolio value fell 1.7% quarter-over-quarter to $6.92B.

Based on C WorldWide Group's 13F filing for Q4 2017, filed 7 Feb 2018.